List of insiders holdings for LIGAND PHARMACEUTICALS INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | Loeb Daniel S Former Director (1) Director |
2007-03-28 16:25:14 | 0 2,027,378 |
2,027,378 | Form 4 |
2 | KNOTT DAVID M Director |
2018-02-13 08:48:23 | 865,500 0 |
865,500 | Form 13G |
3 | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC INVESTMENT 10 LLC BVF INC LAMPERT MARK N 10% Owner |
2015-02-17 16:41:25 | 860,063 0 |
860,063 | Form 13G |
4 | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC LAMPERT MARK N See Explanation of Responses |
2015-02-17 16:41:25 | 860,063 0 |
860,063 | Form 13G |
5 | HIGGINS JOHN L Director |
2022-12-30 17:00:13 | 417,695 0 |
417,695 | Form 4 |
6 | DeSilva Nishan M VP, Finance & Strategy and CFO |
2015-05-14 17:39:50 | 245,399 0 |
245,399 | Form 4 |
7 | Davis Todd C Chief Executive Officer |
2025-03-06 18:54:55 | 245,200 0 |
245,200 | Form 4 |
8 | FOEHR MATTHEW W Former Executive Officer |
2022-11-03 21:06:18 | 162,187 0 |
162,187 | Form 4 |
9 | Aryeh Jason Director |
2024-06-18 21:25:56 | 83,524 56,619 |
140,143 | Form 4 |
10 | MEGLASSON MARTIN V-P, Discovery Research |
2010-05-11 14:14:11 | 102,250 0 |
102,250 | Form 4 |
11 | MAIER PAUL V Sr. V-P, CFO |
2006-11-22 15:58:26 | 94,326 0 |
94,326 | Form 4 |
12 | Korenberg Matthew E President & COO |
2024-09-24 19:41:15 | 93,608 0 |
93,608 | Form 4 |
13 | CROUCH TAYLOR Sr. V-P, Ops & Pres. Int'l |
2006-12-06 19:39:51 | 75,000 0 |
75,000 | Form 4 |
14 | Sharp John P VP Finance and CFO |
2014-02-14 20:18:31 | 65,634 0 |
65,634 | Form 4 |
15 | Reardon Andrew CLO & Secretary |
2025-03-06 18:55:43 | 62,826 0 |
62,826 | Form 4 |
16 | Espinoza Octavio Chief Financial Officer |
2025-03-06 18:55:23 | 59,080 0 |
59,080 | Form 4 |
17 | GOLDMAN SACHS GROUP INC GOLDMAN SACHS & CO. LLC 10% Owner |
2024-11-08 17:34:28 | 52,350 0 |
52,350 | Form 13G |
18 | BROADDUS WARNER R V-P, Gen. Counsel & Secy. |
2006-11-21 18:38:43 | 50,774 0 |
50,774 | Form 4 |
19 | ROBINSON DAVID E Pres, CEO & Chairman |
2006-03-14 16:08:47 | 50,000 0 |
50,000 | Form 4 |
20 | KOZARICH JOHN W Director |
2024-06-18 21:26:49 | 49,219 0 |
49,219 | Form 4 |
21 | Kazmi Syed VP, Bus. Dev. & Strategic Plan |
2012-02-13 14:17:11 | 43,230 0 |
43,230 | Form 4 |
22 | GROVES ERIC S V-P, Project Management |
2006-12-19 18:51:50 | 37,625 0 |
37,625 | Form 4 |
23 | Dziewanowska Zofia E VP, Clinical Research |
2009-02-27 14:11:55 | 33,977 0 |
33,977 | Form 4 |
24 | Perry Jeffrey R Director |
2008-06-02 17:04:38 | 33,953 0 |
33,953 | Form 4 |
25 | Sabba Stephen L Director |
2025-04-16 09:34:19 | 32,584 0 |
32,584 | Form 4 |
26 | Burakoff Steven J Director |
2010-02-19 13:00:51 | 30,000 0 |
30,000 | Form 4 |
27 | LAMATTINA JOHN L Director |
2024-12-02 20:05:58 | 29,515 0 |
29,515 | Form 4 |
28 | Patel Sunil Former Director Director |
2022-11-03 21:06:59 | 28,820 0 |
28,820 | Form 4 |
29 | Dembitz Terry A Vice President, Administration |
2007-03-09 19:15:12 | 24,980 0 |
24,980 | Form 3 |
30 | Berkman Charles S Former Executive Officer |
2022-11-03 21:06:31 | 23,825 0 |
23,825 | Form 4 |
31 | PETTTIT WILLIAM A Sr. V-P, HR and Administration |
2006-12-19 18:51:15 | 22,447 0 |
22,447 | Form 4 |
32 | LITALIEN JAMES J Sr. V-P, Reg Affairs & Comp. |
2006-03-14 16:07:53 | 20,000 0 |
20,000 | Form 4 |
33 | MERTES TOD V-P, Controller & Treasurer |
2006-03-14 16:08:21 | 20,000 0 |
20,000 | Form 4 |
34 | BLISSENBACH HENRY F Director |
2007-04-04 18:06:53 | 15,005 0 |
15,005 | Form 4 |
35 | NEGRO-VILAR ANDRES Exe V-P, R & D, CSO |
2006-12-14 20:39:41 | 14,940 0 |
14,940 | Form 4 |
36 | ALIPRANDI GIAMBATTISTA Sr.V-P, Tech, Sup & Intl Oper |
2004-06-03 15:15:53 | 12,988 0 |
12,988 | Form 4 |
37 | Gray Nancy Ryan Director |
2024-06-18 21:26:16 | 12,329 0 |
12,329 | Form 4 |
38 | Haas Jason Director |
2024-06-18 21:26:37 | 10,841 0 |
10,841 | Form 4 |
39 | PEACOCK BRUCE Director |
2008-12-24 15:07:19 | 10,000 0 |
10,000 | Form 3 |
40 | GROOM JOHN Director |
2006-09-28 14:20:43 | 10,000 0 |
10,000 | Form 4 |
41 | PECK CARL C Director |
2006-09-28 14:21:11 | 10,000 0 |
10,000 | Form 4 |
42 | ROCCA MICHAEL A Director |
2006-09-28 14:21:22 | 10,000 0 |
10,000 | Form 4 |
43 | GREETHAM ELIZABETH M Director |
2008-06-02 15:21:10 | 10,000 0 |
10,000 | Form 4 |
44 | LIGAND PHARMACEUTICALS INC Director |
2008-08-06 18:14:13 | 10,000 0 |
10,000 | Form 4 |
45 | Zimmermann Martine Director |
2024-06-18 21:27:25 | 8,981 0 |
8,981 | Form 4 |
46 | CROSS ALEXANDER D Director |
2007-01-05 13:04:22 | 3,781 0 |
3,781 | Form 4 |
47 | JOHNSON IRVING S Director |
2007-01-05 13:04:36 | 3,781 0 |
3,781 | Form 4 |
48 | Roberts Brigette Director |
2007-01-05 13:02:15 | 3,781 0 |
3,781 | Form 4 |
49 | Herman Melanie J Director of Accounting Director |
2016-07-05 19:56:26 | 3,611 0 |
3,611 | Form 4 |
50 | Boyce Sarah Former Director Director |
2022-11-03 21:06:05 | 2,892 0 |
2,892 | Form 4 |
51 | Cochran Jennifer R. Former Director Director |
2022-11-03 21:08:29 | 1,161 0 |
1,161 | Form 4 |
52 | ELAN CORP PLC 10% Owner |
2003-07-21 20:39:43 | 0 0 |
0 | Form 13D |